Statusfirst Chf (Congestive Heart Failure) Nt-Probnp, Model 20204
Test, Natriuretic Peptide. 510(k) K051596, from Nanogen, Inc. (San Diego, CA). Product code NBC, class 2.
As of Nov 20, 2026, K051596 is an FDA 510(k) held by Nanogen, Inc., substantially equivalent on Mar 13, 2006 after 270 days, with no recalls tied to it in FDA's recall database.
- Review time: 270 days
- Recalls: 0
- Cited as a predicate by: 1 device
StatusFirst™ CHF (Congestive Heart Failure) NT-proBNP is a rapid test for the in-vitro quantitative determination of N-terminal pro-Brain natriuretic peptide (NT-proBNP) in human EDTA plasma. The device is intended for use with the DXpress™ Reader to provide quantitative results as an aid in the diagnosis of CHF.
- Elecsys Probnp ImmunoassayK032646 · Roche Diagnostics Corp. · Nov 12, 2003
- Ramp Nt-Probnp AssayK063662 · Response Biomedical Corp. · Jul 21, 2008
- Access BNP IIK262597 · Beckman Coulter, Inc. · Oct 20, 2026
- Access NT-proBNPK262109 · Beckman Coulter, Inc. · Sep 21, 2026
- Access BNP IIK252169 · Beckman Coulter, Inc. · Mar 24, 2026
- Alere NT-proBNP for Alinity iK253539 · Axis-Shield Diagnostics, Ltd. · Feb 18, 2026
- Alere NT-proBNP for Alinity i Reagent KitK241176 · Axis-Shield Diagnostics, Ltd. · Jan 16, 2025
- Access NT-proBNPK232164 · Beckman Coulter, Inc. · Apr 12, 2024
- ADVIA Centaur® NT-proBNPII (PBNPII)K220265 · Siemens Healthcare Diagnostics, Inc. · Sep 24, 2023
- Elecsys proBNP II, Elecsys proBNP II STATK223637 · Roche Diagnostics · Jul 21, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jun 16, 2005
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1117
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files